Galena Biopharma (GALE) Seeks Shareholder Approval for Reverse Stock Split
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
In its preliminary proxy, Galena Biopharma (NASDAQ: GALE) said it will seek shareholder approval to effect a reverse stock split of the outstanding shares of the Company’s common stock, par value $0.0001 per share, at a ratio of not less than 1 for 2 and not greater than 1 for 20, with the exact ratio and effective time of the reverse stock split to be determined by the Board of Directors and publicly announced by press release.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Galena Biopharma (GALE) PT Raised to $4 at Maxim Group into San Antonio Breast Cancer Symposium
- Galena Biopharma to Present Two Posters at the San Antonio Breast Cancer Symposium
- UPDATE: Stryker (SYK) Raises Quarterly Dividend 11.8% to $0.425; 1.5% Yield
Create E-mail Alert Related CategoriesStock Splits
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!